Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia
A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to hae...
Main Authors: | Mike N. Foster, Anitra C. Carr, Alina Antony, Selene Peng, Mike G. Fitzpatrick |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3921/7/7/92 |
Similar Items
-
The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme
by: Nicola Baillie, et al.
Published: (2018-08-01) -
High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome
by: Fatere Seyedalipour, et al.
Published: (2017-07-01) -
Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia
by: Farinoosh Dadrass, et al.
Published: (2022-08-01) -
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia
by: Tiziana Ottone, et al.
Published: (2022-06-01) -
Ex Vivo Anti-Leukemic Effect of Exosome-like Grapefruit-Derived Nanovesicles from Organic Farming—The Potential Role of Ascorbic Acid
by: Germana Castelli, et al.
Published: (2023-10-01)